What Nerve Growth Factor Does
Nerve growth factor (NGF) is a protein that plays a critical role in the survival, maintenance, and growth of neurons — particularly in the peripheral nervous system and in specific regions of the brain including the hippocampus, basal forebrain, and cortex. NGF was discovered in the 1950s by Rita Levi-Montalcini, who won the Nobel Prize for the work in 1986.
In the brain, NGF supports the survival of cholinergic neurons in the basal forebrain — the neurons that produce acetylcholine, a neurotransmitter critical for memory, learning, and attention. These are precisely the neurons that degenerate in Alzheimer's disease. NGF also promotes neuroplasticity — the brain's ability to form new connections — and has been shown to support recovery from peripheral nerve injury.
The challenge with NGF as a therapeutic agent is that the protein itself cannot cross the blood-brain barrier. This has limited its clinical application despite decades of research. The discovery that certain compounds in lion's mane mushroom can stimulate the brain's own NGF production — from within the brain, bypassing the blood-brain barrier problem — is what makes lion's mane neurologically significant.
The Active Compounds: Hericenones and Erinacines
Lion's mane (Hericium erinaceus) contains two classes of bioactive compounds that stimulate NGF synthesis: hericenones (found in the fruiting body) and erinacines (found in the mycelium). Both classes have been shown to cross the blood-brain barrier and stimulate NGF production in the brain.
The erinacines are particularly potent. A 2009 study in Phytotherapy Research found that erinacine A stimulated NGF synthesis in astrocytes (brain support cells) at concentrations achievable through dietary supplementation. Subsequent animal studies showed that erinacine supplementation increased NGF levels in the hippocampus and olfactory bulb — regions critical for memory and cognitive function.
Human Clinical Evidence
The landmark human trial was published in 2009 in Phytotherapy Research by Mori et al. Thirty patients with mild cognitive impairment were randomised to receive either 3g/day of lion's mane powder or placebo for 16 weeks. The lion's mane group showed significant improvements on the Revised Hasegawa Dementia Scale (a cognitive assessment tool) compared to placebo, with improvements emerging at week 8 and increasing through week 16. Crucially, the improvements reversed when supplementation was stopped — suggesting the effect was dependent on ongoing NGF stimulation.
A 2020 study in Journal of Alzheimer's Disease found that lion's mane extract significantly reduced amyloid-beta plaque formation in a mouse model of Alzheimer's disease, and improved spatial memory and learning. While animal models do not directly translate to human outcomes, the mechanism — NGF-mediated neuroprotection — is consistent with the human cognitive improvement data.
A 2019 pilot study in healthy adults found that lion's mane supplementation improved scores on the Montreal Cognitive Assessment (MoCA) and reduced self-reported anxiety and depression after 4 weeks. The effect size was modest but statistically significant, suggesting benefits even in people without baseline cognitive impairment.
Who Is Most Likely to Benefit
The evidence is strongest for three populations: people with mild cognitive impairment or early-stage dementia, people recovering from peripheral nerve injury (where NGF plays a direct role in nerve regeneration), and people with depression or anxiety (where the hippocampal neuroplasticity effects may be relevant).
For healthy adults seeking cognitive enhancement, the evidence is more limited — the 2019 pilot study is promising but small. The most honest summary is that lion's mane appears to support the maintenance of existing cognitive function more than it dramatically enhances it in people who are already neurologically healthy.
The standard clinical dose used in trials is 3–5g/day of dried fruiting body powder, or 500–1000mg of a concentrated extract standardised to hericenone content. Effects typically emerge at 4–8 weeks of consistent supplementation.